Semaglutide

A GLP‑1 receptor agonist with proven ASCVD benefit and strong weight loss is a great candidate drug for patients with cardiovascular disease and obesity. However, it is preferred for HFpEF and it has not been shown to reduce HFrEF hospitalization. It may be added later for weight or ASCVD risk, but it does not replace another cardioprotective drug for HF benefit as a first step.

  • Further Developments
End Session and View Feedback
  • Peter pomaga mami. [undo]
  • Πανοραμική ακτινογραφία. [undo]
  • Quantification of bacterial load: Serial dilutions [undo]
  • Description of cells 3 [undo]
  • [undo]
  • Opțiunea 1: Pentru siguranța noastră și a colegilor noștri în timpul și după practica de laborator [undo]
  • Examination [undo]
  • Sitagliptin [undo]
  • Total Body CT scan [undo]
  • Ενδοφλέβια δεξαμεθαζόνη [undo]
  • Adverse effect to budesonide [undo]
  • Protein Synthesis [undo]
  • Opțiunea 2: Doar B este corectă [undo]
  • Option 3 [undo]
  • Option 2 [undo]
  • Node 3: Address each concern in detail [undo]
  • Activates somatostatin receptors [undo]
  • Προτείνεις να δουλέψουμε μαζί τους στο νοσοκομείο. [undo]
  • ΜΕΤΑΒΟΛΙΣΜΟΣ ΤΩΝ ΚΥΤΤΑΡΙΚΩΝ ΕΝΖΥΜΩΝ (PH/ΘΕΡΜΟΚΡΑΣΙΑ) [undo]
  • Πρωτεϊνοσύνθεση [undo]
  • new node [undo]
  • Quit therapy for now [undo]
  • Mitosis [undo]
  • MSA [undo]
  • Focus on karyotypes. [undo]
  • Stay in therapy (continue with CBT sessions) [undo]
  • Areas B, C and D are contaminated. [undo]
  • Preload [undo]
  • Opțiunea 2: Pentru a identifica și manipula corespunzător materialele periculoase din laborator [undo]
  • Privacy risk [undo]
  • Home Visit [undo]
  • Obj Examination [undo]
  • Increases her coffee intake [undo]
  • Επιλογή 1 [undo]
  • To protect our clothes underneath. White matches with any skin colour tone [undo]
  • Ask the patient to walk or change position (risk of falling). [undo]
  • Emulsion Test [undo]
  • Răspunsul 2 [undo]
  • Genome Sequencing [undo]
  • Start a therapy [undo]
  • Amlodipine (calcium channel blocker) [undo]
  • Πολυμεράση Taq [undo]
  • Tell the patient to change devices without giving proper guidance. [undo]
  • Semaglutide [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21100
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Option 1
  • Peter pomaga mami.
  • Πανοραμική ακτινογραφία.
  • Quantification of bacterial load: Serial dilutions
  • Description of cells 3
  • Opțiunea 1: Pentru siguranța noastră și a colegilor noștri în timpul și după practica de laborator
  • Examination
  • Sitagliptin
  • Total Body CT scan
  • Ενδοφλέβια δεξαμεθαζόνη
  • Adverse effect to budesonide
  • Protein Synthesis
  • Opțiunea 2: Doar B este corectă
  • Option 3
  • Option 2
  • Node 3: Address each concern in detail
  • Activates somatostatin receptors
  • Προτείνεις να δουλέψουμε μαζί τους στο νοσοκομείο.
  • ΜΕΤΑΒΟΛΙΣΜΟΣ ΤΩΝ ΚΥΤΤΑΡΙΚΩΝ ΕΝΖΥΜΩΝ (PH/ΘΕΡΜΟΚΡΑΣΙΑ)
  • Πρωτεϊνοσύνθεση
  • new node
  • Quit therapy for now
  • Mitosis
  • MSA
  • Focus on karyotypes.
  • Stay in therapy (continue with CBT sessions)
  • Areas B, C and D are contaminated.
  • Preload
  • Opțiunea 2: Pentru a identifica și manipula corespunzător materialele periculoase din laborator
  • Privacy risk
  • Home Visit
  • Obj Examination
  • Increases her coffee intake
  • Επιλογή 1
  • To protect our clothes underneath. White matches with any skin colour tone
  • Ask the patient to walk or change position (risk of falling).
  • Emulsion Test
  • Răspunsul 2
  • Genome Sequencing
  • Start a therapy
  • Amlodipine (calcium channel blocker)
  • Πολυμεράση Taq
  • Tell the patient to change devices without giving proper guidance.
  • Semaglutide

Reminder

empty_reminder_msg

FINISH

Time is up